Skip to main content
ZCARW
OTC Trade & Services

Zoomcar Closes $75,000 Tranche as Preferred Conversion Price Resets to $0.0116, Triggering Heavy Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
8
Price
$0.004
Mkt Cap
$4.897M
52W Low
$0
52W High
$0.04
52W Position
Off High info
91% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ZCARW filed a Financing and Capital Events on light trading volume (0.3× avg).

Summary

Zoomcar closed the seventh tranche of its Series A placement for about $75,000, and the issuance triggered a price reset cutting preferred conversion and warrant exercise prices to $0.0116 — substantially dilutive to common holders. The company also disclosed an OTCQB notice that its public float is below 10% of shares outstanding, with a cure deadline of December 21, 2026.


Key Events · Financing and Capital Events · ZCARW

  • Seventh Tranche Closes at $75,000

    75 Series A Units sold at $1,000 per Unit on October 23, 2026, each unit one preferred share plus one warrant for 20,000 common shares, for about $75,000 gross before placement agent fees and expenses.

  • Conversion Price Reset to $0.0116

    The reset cut the Series A preferred conversion price from $0.05 to $0.0116 and the warrant exercise price from $0.0625 to $0.0116, applying to all outstanding preferred shares and warrants, not only the new issuance.

  • Preferred Now Converts Into 86,206 Shares

    At the reset price each preferred share converts into 86,206 common shares versus 20,000 at the initial $0.05 price; the 75 preferred shares sold in this tranche convert into 6,465,450 common shares, and the company states the reset is substantially dilutive to common holders.

  • OTCQB Public Float Deficiency

    OTC Markets notified the company on September 22, 2026 that public float was below 10% of total shares outstanding under Section 4.1 of the OTCQB Standards, with a 90-day cure period through December 21, 2026 before the stock may be removed from the OTCQB Venture Market.


Analysis · ZCARW · Trade & Services

The headline number is tiny — 75 units at $1,000 each, about $75,000 gross — but the real story is the reset it triggered. Conversion and exercise prices on the Series A preferred and warrants were cut from $0.05 and $0.0625 to $0.0116, and the reset applies to every outstanding preferred share and warrant, not just the new ones. Each preferred share now converts into 86,206 common shares instead of 20,000, so the 75 preferred shares sold here alone convert into 6,465,450 shares, and the same multiplication applies to the entire outstanding Series A stack. The company itself calls the result substantially dilutive to common holders. Layered on top is an OTCQB notice received September 22, 2026 that public float is below the required 10% of shares outstanding, with a cure deadline of December 21, 2026 — a listing risk that sits directly against the dilution the reset creates. The company says it may submit a cure plan and is weighing an uplisting, but there is no assurance either happens.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ZCARW was trading at $0.00 on OTC in the Trade & Services sector, with a market capitalization of approximately $4.9M. The 52-week trading range was $0.00 to $0.04. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ZCARW - Latest Insights

ZCARW
Aug 31, 2026, 4:01 PM EDT
Filing Type: SC TO-I/A
Importance Score:
8